Abstract
The WHO separates marginal zone B-cell lymphomas (MZBL) of nodal and extranodal type. Both arise from memory B cells of the marginal zone. Extranodal MZBL of the mucosa-associated lymphatic tissue (MALT) have characteristic features such as homing in epithelial tissue, lymphoepithelial destruction, and a very indolent clinical course. They arise in epithelial tissues normally devoid of lymphatic cells, where the lymphatic tissue was acquired after, for instance, a chronic infection. The best example here is infection of the stomach with Helicobacter pylori (Hp). Besides the classical association with gastric MALT lymphomas, there have been reports in which an association between Hp and diffuse large B-cell lymphoma (DLBCL) has been observed as well. Consequently, cure of Hp infection resulted in remission induction not only in gastric MALT lymphomas, but also in some patients with very limited stages of DLBCL of the stomach. In addition to the association with Hp, progress has been made with regard to MALT lymphoma biology. Translocation t(1;14) involving the Bcl-10 gene, and translocation t(11;18) involving a novel gene called MLT1, both result in activation of the crucial transcription factor NF-kappaB. These genetic events seem specific in that they have been observed only in MALT lymphomas. Once present, at least the more frequently observed translocation t(11;18) renders cells resistant to cure of Hp infection. Another clinically important question is that in many patients in complete remission after cure of Hp infection, detection of minimal residual disease is positive. Whether these cells are normal memory B cells (with the identical B-cell rearrangement as the original lymphoma clone), or dormant lymphoma cells, is unclear at present. In patients not responding to cure of Hp infection, several treatment options are discussed. MALT lymphomas have opened up a new discussion of lymphoma biology and have thus been called a model disease.
Similar content being viewed by others
References
Stolte M, Bayerdorffer E, Morgner A, Alpen B, Wundisch T, Thiede C, Neubauer A (2002) Helicobacter and gastric MALT lymphoma. Gut 50:iii19–24
Cavalli F, Isaacson PG, Gascoyne RD, Zucca E (2001) MALT lymphomas. Hematology (Am Soc Hematol Educ Program) 241–258
Chan JK, Ng CS, Isaacson PG (1990) Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol 136:1153–1164
de Jong D, Boot H, van Heerde P, Hart GA, Taal BG (1997) Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 112:1466–1474
Isaacson P, Wright DH (1983) Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 52:1410–1416
Wyatt JI, Rathbone BJ (1988) Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol 142 [Suppl]:44–49
Stolte M, Eidt S (1989) Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? J Clin Pathol 42:1269–1271
Genta RM, Hamner HW, Graham DY (1993) Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol 24:577–583
Solcia E, Villani L, Fiocca R, Luinetti O, Boldorini R, Trespi E, Perego M, Alvisi C, Lazzaroni M, Bianchi Porro G (1994) Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol 201 [Suppl]:28–34
Oberhuber G, Puspok A, Dejaco C, Hammer J, Zauner C, Pfeffel F, Fiedler R, Potzi R, Allerberger F, Wrba F (1996) Minimal chronic inactive gastritis: indicator of pre-existing Helicobacter pylori gastritis? Pathol Res Pract 192:1016–1021
van der Hulst RW, van der Ende A, Dekker FW, Ten Kate FJ, Weel JF, Keller JJ, Kruizinga SP, Dankert J, Tytgat GN (1997) Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 113:25–30
Chen XY, Liu WZ, Shi Y, Zhang DZ, Xiao SD, Tytgat GN (2002) Helicobacter pylori associated gastric diseases and lymphoid tissue hyperplasia in gastric antral mucosa. J Clin Pathol 55:133–137
Doglioni C, Wotherspoon AC, Moschini A, de Boni M, Isaacson PG (1992) High incidence of primary gastric lymphoma in northeastern Italy. Lancet 339:834–835
Cogliatti SB, Schmid U, Schumacher U, Eckert F, Hansmann ML, Hedderich J, Takahashi H, Lennert K (1991) Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 101:1159–1170
Eidt S, Stolte M, Fischer R (1994) Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas. J Clin Pathol 47:436–439
Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267–1271
Zucca E, Bertoni F, Roggero E, Bosshard G, Cazzaniga G, Pedrinis E, Biondi A, Cavalli F (1998) Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 338:804–810
Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575–577
Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M (1995) Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 345:1591–1594
Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, Pedrinis E, Paterlini A, Venco A, Cavalli F (1995) Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 122:767–769
Weismuller J, Seifert E, Goronzy R, Stolte M (1986) Malignant lymphoma of the stomach: progress in early diagnosis (in German). Schweiz Rundsch Med Prax 75:1531–1532
Eidt S, Stolte M (1994) Evidence of a malignant cycle in early gastric lymphoma. Endoscopy 26:299–302
Wotherspoon AC, Doglioni C, Isaacson PG (1992) Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology 20:29–34
Isaacson PG, Spencer J (1987) Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 11:445–462
Isaacson PG, Wotherspoon AC, Diss T, Pan LX (1991) Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Surg Pathol 15:819–828
Spencer J, Finn T, Pulford KA, Mason DY, Isaacson PG (1985) The human gut contains a novel population of B lymphocytes which resemble marginal zone cells. Clin Exp Immunol 62:607–612
Sackmann M, Morgner A, Rudolph B, Neubauer A, Thiede C, Schulz H, Kraemer W, Boersch G, Rohde P, Seifert E, Stolte M, Bayerdoerffer E (1997) Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology 113:1087–1090
Fusaroli P, Buscarini E, Peyre S, Federici T, Parente F, De Angelis C, Bonanno G, Meroni E, Napolitano V, Pisani A, Sottili S, Togliani T, Caletti G (2002) Interobserver agreement in staging gastric malt lymphoma by EUS. Gastrointest Endosc 55:662–668
Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM, McLaughlin PW, Rodriguez MA, Romaguera JE, Sarris AH, Younes A, Luthra R, Manning JT, Johnson CM, Lahoti S, Shen Y, Lee JE, Winn RJ, Genta RM, Graham DY, Cabanillas FF (1999) Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 131:88–95
Qin Y, Greiner A, Trunk MJ, Schmausser B, Ott MM, Muller-Hermelink HK (1995) Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood 86:3528–3534
Du MQ, Xu CF, Diss TC, Peng HZ, Wotherspoon AC, Isaacson PG, Pan LX (1996) Intestinal dissemination of gastric mucosa-associated lymphoid tissue lymphoma. Blood 88:4445–4451
Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L (1996) Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 10:1190–1197
Thiede C, Alpen B, Morgner A, Schmidt M, Ritter M, Ehninger G, Stolte M, Bayerdorffer E, Neubauer A (1998) Ongoing somatic mutations and clonal expansions after cure of Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 16:3822–3831
Du MQ, Isaccson PG (2002) Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 3:97–104
Hussell T, Isaacson PG, Crabtree JE, Spencer J (1993) The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342:571–574
Hussell T, Isaacson PG, Crabtree JE, Dogan A, Spencer J (1993) Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type. Am J Pathol 142:285–292
Greiner A, Knorr C, Qin Y, Sebald W, Schimpl A, Banchereau J, Muller-Hermelink HK (1997) Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol 150:1583–1593
D'Elios MM, Amedei A, Manghetti M, Costa F, Baldari CT, Quazi AS, Telford JL, Romagnani S, Del Prete G (1999) Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. Gastroenterology 117:1105–1112
Riedel S, Kraft M, Kucharzik T, Pauels HG, Tiemann M, Steinbuchel A, Domschke W, Lugering N (2001) CD4+ Th1-cells predominate in low-grade B-cell lymphoma of gastric mucosa-associated lymphoid tissue (MALT type). Scand J Gastroenterol 36:1198–1203
Auer IA, Gascoyne RD, Connors JM, Cotter FE, Greiner TC, Sanger WG, Horsman DE (1997) t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol 8:979–985
Baens M, Maes B, Steyls A, Geboes K, Marynen P, De Wolf-Peeters C (2000) The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 156:1433–1439
Kalla J, Stilgenbauer S, Schaffner C, Wolf S, Ott G, Greiner A, Rosenwald A, Dohner H, Muller-Hermelink HK, Lichter P (2000) Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma. Leukemia 14:1967–1974
Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi RA, Diss TC, Dogan A, Megraud F, Rambaud JC, Du MQ, Isaacson PG (2001) Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357:39–40
Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wundisch T, Molina T, Taal BG, Elena S, Thomas T, Zinzani PL, Neubauer A, Stolte M, Hamoudi RA, Dogan A, Isaacson PG, Du MQ (2002) T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 122:1286–1294
Motegi M, Yonezumi M, Suzuki H, Suzuki R, Hosokawa Y, Hosaka S, Kodera Y, Morishima Y, Nakamura S, Seto M (2000) API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 156:807–812
Ott G, Katzenberger T, Greiner A, Kalla J, Rosenwald A, Heinrich U, Ott MM, Muller-Hermelink HK (1997) The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 57:3944–3948
Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK, De Wolf-Peeters C, Hagemeijer A, Van den Berghe H, Marynen P (1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21)p6ssociated with mucosa-associated lymphoid tissue lymphomas. Blood 93:3601–3609
Akagi T, Motegi M, Tamura A, Suzuki R, Hosokawa Y, Suzuki H, Ota H, Nakamura S, Morishima Y, Taniwaki M, Seto M (1999) A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 18:5785–5794
Morgan JA, Yin Y, Borowsky AD, Kuo F, Nourmand N, Koontz JI, Reynolds C, Soreng L, Griffin CA, Graeme-Cook F, Harris NL, Weisenburger D, Pinkus GS, Fletcher JA, Sklar J (1999) Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res 59:6205–6213
Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, Price H, Karran L, Majekodunmi O, Wlodarska I, Pan L, Crook T, Hamoudi R, Isaacson PG, Dyer MJ (1999) Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96:35–45
Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L, Rakestraw KM, Naeve CW, Beckmann G, Weisenburger DD, Sanger WG, Nowotny H, Vesely M, Callet-Bauchu E, Salles G, Dixit VM, Rosenthal A, Schlegelberger B, Morris SW (1999) Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 22:63–68
Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF, Yamaoka S, Seto M, Nunez G (2001) Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 276:19012–19019
Du MQ, Peng H, Liu H, Hamoudi RA, Diss TC, Willis TG, Ye H, Dogan A, Wotherspoon AC, Dyer MJ, Isaacson PG (2000) BCL10 gene mutation in lymphoma. Blood 95:3885–3890
Maes B, Demunter A, Peeters B, De Wolf-Peeters C (2002) BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression. Blood 99:1398–1404
Ye H, Dogan A, Karran L, Willis TG, Chen L, Wlodarska I, Dyer MJ, Isaacson PG, Du MQ (2000) BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. Am J Pathol 157:1147–1154
Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, Koonin EV, Dixit VM (2000) Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 6:961–967
Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I, Isaacson PG, Du MQ (2001) T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 98:1182–1187
Alpen B, Neubauer A, Dierlamm J, Marynen P, Thiede C, Bayerdorfer E, Stolte M (2000) Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 95:4014–4015
Nakamura T, Nakamura S, Yonezumi M, Suzuki T, Matsuura A, Yatabe Y, Yokoi T, Ohashi K, Seto M (2000) Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J Cancer Res 91:301–309
Remstein ED, Kurtin PJ, James CD, Wang XY, Meyer RG, Dewald GW (2002) Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. Am J Pathol 161:63–71
Starostik P, Patzner J, Greiner A, Schwarz S, Kalla J, Ott G, Muller-Hermelink HK (2002) Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 99:3–9
Barth TF, Bentz M, Leithauser F, Stilgenbauer S, Siebert R, Schlotter M, Schlenk RF, Dohner H, Moller P (2002) Pathogenic complexity of gastric B-cell lymphoma. Blood 100:1095–1096, discussion 1096–1097
Streubel B, Lamprecht A, Dierlamm J, Cerroni L, Stolte M, Ott G, Raderer M, Chott A (2003) T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 101:2335–2339
Du M, Peng H, Singh N, Isaacson PG, Pan L (1995) The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 86:4587–4593
Dierlamm J, Pittaluga S, Wlodarska I, Stul M, Thomas J, Boogaerts M, Michaux L, Driessen A, Mecucci C, Cassiman JJ, et al. (1996) Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 87:299–307
de Wolf-Peeters C, Pittaluga S, Dierlamm J, Wlodarska I, Van Den Berghe H (1997) Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone. Leuk Lymphoma 26:467–478
Peng H, Diss T, Isaacson PG, Pan L (1997) c-myc gene abnormalities in mucosa-associated lymphoid tissue (MALT) lymphomas. J Pathol 181:381–386
Martinez-Delgado B, Fernandez-Piqueras J, Garcia MJ, Arranz E, Gallego J, Rivas C, Robledo M, Benitez J (1997) Hypermethylation of a 5' CpG island of p16 is a frequent event in non-Hodgkin's lymphoma. Leukemia 11:425–428
Gronbaek K, Straten PT, Ralfkiaer E, Ahrenkiel V, Andersen MK, Hansen NE, Zeuthen J, Hou-Jensen K, Guldberg P (1998) Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood 92:3018–3024
Martinez-Delgado B, Robledo M, Arranz E, Osorio A, Garcia MJ, Echezarreta G, Rivas C, Benitez J (1998) Hypermethylation of p15/ink4b/MTS2 gene is differentially implicated among non-Hodgkin's lymphomas. Leukemia 12:937–941
Ohashi S, Segawa K, Okamura S, Urano H, Kanamori S, Ishikawa H, Hara K, Hukutomi A, Shirai K, Maeda M (2000) A clinicopathologic study of gastric mucosa-associated lymphoid tissue lymphoma. Cancer 88:2210–2219
Wan JH, Sykes PJ, Orell SR, Morley AA (1992) Rapid method for detecting monoclonality in B cell lymphoma in lymph node aspirates using the polymerase chain reaction. J Clin Pathol 45:420–423
Algara P, Martinez P, Sanchez L, Villuendas R, Benitez J, Rivas C, Piris MA (1993) The detection of B-cell monoclonal populations by polymerase chain reaction: accuracy of approach and application in gastric endoscopic biopsy specimens. Hum Pathol 24:1184–1188
Ling FC, Clarke CE, Corbett WE, Lillicrap DP (1993) Sensitivity of PCR in detecting monoclonal B cell proliferations. J Clin Pathol 46:624–627
Diss TC, Pan L, Peng H, Wotherspoon AC, Isaacson PG (1994) Sources of DNA for detecting B cell monoclonality using PCR. J Clin Pathol 47:493–496
De Re V, De Vita S, Carbone A, Ferraccioli G, Gloghini A, Marzotto A, Pivetta B, Dolcetti R, Boiocchi M (1995) The relevance of VDJ PCR protocols in detecting B-cell clonal expansion in lymphomas and other lymphoproliferative disorders. Tumori 81:405–409
Lozano MD, Tierens A, Greiner TC, Wickert RS, Weisenburger DD, Chan WC (1996) Clonality analysis of B-lymphoid proliferations using the polymerase chain reaction. Cancer 77:1349–1355
Bertoni F, Cazzaniga G, Bosshard G, Roggero E, Barbazza R, De Boni M, Capella C, Pedrinis E, Cavalli F, Biondi A, Zucca E (1997) Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process. Br J Haematol 97:830–836
Miklos JA, Swerdlow SH, Bahler DW (2000) Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1–69 with distinctive CDR3 features. Blood 95:3878–3884
Aiello A, Giardini R, Tondini C, Balzarotti M, Diss T, Peng H, Delia D, Pilotti S (1999) PCR-based clonality analysis: a reliable method for the diagnosis and follow-up monitoring of conservatively treated gastric B-cell MALT lymphomas? Histopathology 34:326–330
Bertoni F, Conconi A, Capella C, Motta T, Giardini R, Ponzoni M, Pedrinis E, Novero D, Rinaldi P, Cazzaniga G, Biondi A, Wotherspoon A, Hancock BW, Smith P, Souhami R, Cotter FE, Cavalli F, Zucca E (2002) Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood 99:2541–2544
Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, de Argila CM, Bellas C (2001) Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica 86:609–617
Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B, Wundisch T, Ehninger G, Stolte M, Bayerdorffer E (1997) Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 89:1350–1335
Thiede C, Wundisch T, Neubauer B, Alpen B, Morgner A, Ritter M, Ehninger G, Stolte M, Bayerdorffer E, Neubauer A (2000) Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial. Recent Results Cancer Res 156:125–133
Savio A, Franzin G, Wotherspoon AC, Zamboni G, Negrini R, Buffoli F, Diss TC, Pan L, Isaacson PG (1996) Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood 87:1255–1260
Calvert RJ, Evans PA, Randerson JA, Jack AS, Morgan GJ, Dixon MF (1996) The significance of B-cell clonality in gastric lymphoid infiltrates. J Pathol 180:26–32
Sorrentino D, Ferraccioli GF, DeVita S, Avellini C, Beltrami CA, Labombarda A, Bernardis V, De Biase F, Trevisi A, Pivetta B, Boiocchi M, Bartoli E (1996) B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma. Gut 38:837–840
Ferraccioli GF, Sorrentino D, De Vita S, Casatta L, Labombarda A, Avellini C, Dolcetti R, Di Luca D, Beltrami CA, Boiocchi M, Bartoli E (1996) B cell clonality in gastric lymphoid tissues of patients with Sjogren's syndrome. Ann Rheum Dis 55:311–316
Hsi ED, Greenson JK, Singleton TP, Siddiqui J, Schnitzer B, Ross CW (1996) Detection of immunoglobulin heavy chain gene rearrangement by polymerase chain reaction in chronic active gastritis associated with Helicobacter pylori. Hum Pathol 27:290–296
Rudolph B, Bayerdorffer E, Ritter M, Muller S, Thiede C, Neubauer B, Lehn N, Seifert E, Otto P, Hatz R, Stolte M, Neubauer A (1997) Is the polymerase chain reaction or cure of Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated lymphatic tissue lymphoma? J Clin Oncol 15:1104–1109
de Mascarel A, Dubus P, Belleannee G, Megraud F, Merlio JP (1998) Low prevalence of monoclonal B cells in Helicobacter pylori gastritis patients with duodenal ulcer. Hum Pathol 29:784–790
Torlakovic E, Cherwitz DL, Jessurun J, Scholes J, McGlennen R (1997) B-cell gene rearrangement in benign and malignant lymphoid proliferations of mucosa-associated lymphoid tissue and lymph nodes. Hum Pathol 28:166–173
El-Zimaity HM, El-Zaatari FA, Dore MP, Oweiss S, Gutierrez O, Yuksul M, Ramchatesingh J, Graham DY (1999) The differential diagnosis of early gastric mucosa-associated lymphoma: polymerase chain reaction and paraffin section immunophenotyping. Mod Pathol 12:885–893
Saxena A, Moshynska O, Kanthan R, Bhutani M, Maksymiuk AW, Lukie BE (2000) Distinct B-cell clonal bands in Helicobacter pylori gastritis with lymphoid hyperplasia. J Pathol 190:47–54
Hiyama T, Haruma K, Kitadai Y, Miyamoto M, Tanaka S, Yoshihara M, Sumii K, Shimamoto F, Kajiyama G (2001) B-cell monoclonality in Helicobacter pylori-associated chronic atrophic gastritis. Virchows Arch 438:232–237
Ludwig CU, Gencik M, Shipman R (1993) Multistep transformation in low-grade lymphoproliferative diseases. Ann Oncol 4:825–830
Thiede C, Wundisch T, Alpen B, Neubauer B, Morgner A, Schmitz M, Ehninger G, Stolte M, Bayerdorffer E, Neubauer A (2001) Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 19:1600–1609
Alpen B, Thiede C, Wundisch T, Bayerdorffer E, Stolte M, Neubauer A (2001) Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori eradication therapy. Clin Lymphoma 2:103–108
Au WY, Gascoyne RD, Le N, Viswanatha DS, Klasa RJ, Gallagher R, Connors JM (1999) Incidence of second neoplasms in patients with MALT lymphoma: no increase in risk above the background population. Ann Oncol 10:317–321
Montalban C, Castrillo JM, Lopez-Abente G, Abraira V, Serrano M, Bellas C, Piris MA, Carrion R, Cruz MA, Garcia-Larana J, Menarguez J, Rivas C (1999) Other cancers in patients with gastric MALT lymphoma. Leuk Lymphoma 33:161–168
Zucca E, Pinotti G, Roggero E, Comi MA, Pascarella A, Capella C, Pedrinis E, Cavalli F (1995) High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma. Ann Oncol 6:726–728
Morgner A, Miehlke S, Stolte M, Neubauer A, Alpen B, Thiede C, Klann H, Hierlmeier FX, Ell C, Ehninger G, Bayerdorffer E (2001) Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. World J Gastroenterol 7:248–253
Rosen CB, van Heerden JA, Martin JK, Jr., Wold LE, Ilstrup DM (1987) Is an aggressive surgical approach to the patient with gastric lymphoma warranted? Ann Surg 205:634–640
Schechter NR, Yahalom J (2000) Low-grade MALT lymphoma of the stomach: a review of treatment options. Int J Radiat Oncol Biol Phys 46:1093–1103
Gobbi PG, Dionigi P, Barbieri F, Corbella F, Bertoloni D, Grignani G, Jemos V, Pieresca C, Ascari E (1990) The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature. Cancer 65:2528–2536
Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, Grothaus-Pinke B, Reinartz G, Brockmann J, Temmesfeld A, Schmitz R, Rube C, Probst A, Jaenke G, Bodenstein H, Junker A, Pott C, Schultze J, Heinecke A, Parwaresch R, Tiemann M (2001) Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma—results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol 19:3874–3883
Bartlett DL, Karpeh MS, Jr., Filippa DA, Brennan MF (1996) Long-term follow-up after curative surgery for early gastric lymphoma. Ann Surg 223:53–62
Rodriguez-Sanjuan JC, Alvarez-Canas C, Casado F, Garcia-Castrillo L, Casanova D, Val-Bernal F, Naranjo A (1999) Results and prognostic factors in stage I(E)-II(E) primary gastric lymphoma after gastrectomy. J Am Coll Surg 188:296–303
Mafune KI, Tanaka Y, Suda Y, Izumo T (2001) Outcome of patients with non-Hodgkin's lymphoma of the stomach after gastrectomy: clinicopathologic study and reclassification according to the revised European-American lymphoma classification. Gastric Cancer 4:137–143
Schechter NR, Portlock CS, Yahalom J (1998) Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 16:1916–1921
Yahalom J (2001) MALT lymphomas: a radiation oncology viewpoint. Ann Hematol 80 [Suppl 3]:B100–B105
Hammel P, Haioun C, Chaumette MT, Gaulard P, Divine M, Reyes F, Delchier JC (1995) Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 13:2524–2529
Jager G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, Neumann HJ, Mlineritsch B, DeSantis M, Quehenberger F, Chott A, Beham-Schmid C, Hofler G, Linkesch W, Raderer M (2002) Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 20:3872–3877
Conconi A, Thieblemont C, Martinelli G, Ferreri AJ, Devizzi L, Peccatori F, Dell'Oro S, Filipazzi V, Dietrich PY, Gianni MA, Coiffier B, Cavalli F, Zucca E (2002) IELSG phase II study of rituximab in MALT lymphoma: final results. ASCO Meeting, Orlando, FL
Fischbach W, Goebeler-Kolve M, Starostik P, Greiner A, Muller-Hermelink HK (2002) Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet 360:547–548
Peng H, Du M, Diss TC, Isaacson PG, Pan L (1997) Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma. Histopathology 30:425–429
Neumeister P, Hoefler G, Beham-Schmid C, Schmidt H, Apfelbeck U, Schaider H, Linkesch W, Sill H (1997) Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas. Gastroenterology 112:1871–1875
Peng H, Chen G, Du M, Singh N, Isaacson PG, Pan L (1996) Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue. Am J Pathol 148:643–648
Sonoki T, Harder L, Horsman DE, Karran L, Taniguchi I, Willis TG, Gesk S, Steinemann D, Zucca E, Schlegelberger B, Sole F, Mungall AJ, Gascoyne RD, Siebert R, Dyer MJ (2001) Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood 98:2837–2844
Chen LT, Lin JT, Shyu RY, Jan CM, Chen CL, Chiang IP, Liu SM, Su IJ, Cheng AL (2001) Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 19:4245–4251
Alpen B, Robbecke J, Wundisch T, Stolte M, Neubauer A (2001) Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL). Ann Hematol 80 [Suppl 3]:B106–B107
Gretschel S, Hunerbein M, Foss HD, Krause M, Schlag PM (2001) Regression of high-grade gastric B-cell lymphoma after eradication of Helicobacter pylori. Endoscopy 33:805–807
Salam I, Durai D, Murphy JK, Sundaram B (2001) Regression of primary high-grade gastric B-cell lymphoma following Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 13:1375–1378
Morgner A, Miehlke S, Fischbach W, Schmitt W, Muller-Hermelink H, Greiner A, Thiede C, Schetelig J, Neubauer A, Stolte M, Ehninger G, Bayerdorffer E (2001) Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol 19:2041–2048
Hiyama T, Haruma K, Kitadai Y, Ito M, Masuda H, Miyamoto M, Tanaka S, Yoshihara M, Sumii K, Shimamoto F, Chayama K (2001) Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability. Int J Oncol 18:1207–1212
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was kindly supported by Deutsche Krebshilfe Bonn (70.2251) and the Wilhelm Sander Stiftung
Rights and permissions
About this article
Cite this article
Wündisch, T., Kim, T.D., Thiede, C. et al. Etiology and therapy of Helicobacter pylori-associated gastric lymphomas. Ann Hematol 82, 535–545 (2003). https://doi.org/10.1007/s00277-003-0677-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-003-0677-2